Sort by
Refine Your Search
-
Listed
-
Category
-
Employer
- Helmholtz-Zentrum Berlin für Materialien und Energie
- Chemie HU Berlin
- Free University of Berlin
- Fritz Haber Institute of the Max Planck Society, Berlin
- Helmholtz Zentrum Berlin
- Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP) im Forschungsverbund Berlin
- Max Planck Institute for Infection Biology •
-
Field
-
15 Apr 2024 Job Information Organisation/Company Chemie HU Berlin Department Chemistry Research Field Chemistry » Biochemistry Researcher Profile First Stage Researcher (R1) Country Germany
-
Job Offer from March 15, 2024 The International Max Planck Research School for Elementary Processes in Physical Chemistry (IMPRS-EPPC) at the Fritz Haber Institute of the Max Planck Society offers 5
-
24 May 2024 Job Information Organisation/Company Helmholtz Zentrum Berlin Research Field Chemistry » Applied chemistry Physics » Chemical physics Researcher Profile First Stage Researcher (R1
-
information can be found at www.grk2662.de . Requirements: Completed university degree (M.Sc. or Diploma degree in) biotechnology, biochemistry, chemistry, biophysics or related subjects. Desirable
-
chemistry, or material science. Knowledge in the operation of ultrahigh vacuum equipment and using X-ray spectroscopies is highly beneficial. Background in photovoltaic materials research is appreciated but
-
preparing publications in peer-reviewed journal. Your Profile M.Sc. in (Electro)Chemistry, Physics, Electrical Engineering, Materials Sciences or equivalent qualification Experience in setting-up, operating
-
Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP) im Forschungsverbund Berlin | Berlin, Berlin | Germany | about 1 month ago
29 Apr 2024 Job Information Organisation/Company Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP) im Forschungsverbund Berlin Research Field Chemistry Researcher Profile First Stage
-
protein chemistry. The Institute promotes the applications of its research towards paving the way for the design of rational measures of control of infectious diseases. The Institute moved to a specially